ADHD is one of the most common neurodevelopmental disorders among children. One in five high school boys and one in 11 high school girls currently live with an ADHD diagnosis. Now, thanks to Harmonyx Diagnositcs, parents of children diagnosed with ADHD have an easy way to determine which prescription drug can best help their child.
Costing less than $100, The Harmonyx Test for ADHD helps bridge the gap in therapeutic outcomes between patients who respond well to initial therapies and those who do not. The test is ideal for patients with new or recent ADHD diagnoses, patients currently undergoing ineffective ADHD treatment and those interested in a stimulant alternative.
“We are seeing all too often a trial-and-error approach to the prescription process,” said Bob Bean, President and CEO of Harmonyx. “This is a slow and inadequate way to help those diagnosed with ADHD get the effective treatment they need. Our affordable new test gives caregivers, parents and patients the ability to make informed decisions about the medications they choose.”
Read the full press release: http://finance.yahoo.com/news/harmonyx-releases-affordable-adhd-genetic-143000378.html